Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes

Heart and Vessels

Volumn 23, Issue 3, 2008, Pages 181-186

  Karavidas, Apostolos ^a   Lazaros, George ^a,c   Matsakas, Evangelos ^a   Farmakis, Dimitrios ^b   Parissis, John ^b   Paraskevaidis, Ioannis A ^b   Michailidis, Christos ^a   Avramidis, Dimitrios ^a   Zacharoulis, Achilleas ^a   Arapi, Sophia ^a   Kaoukis, Andreas ^a   Zacharoulis, Apostolos ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

B type natriuretic peptide; Doppler echocardiography; Heart failure; Left ventricular filling pressure; Tissue Doppler imaging

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECELERATION; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE BLOOD FLOW; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; SWAN GANZ CATHETER; SYSTOLIC HEART FAILURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PULMONARY WEDGE PRESSURE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 44249086161     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-007-1022-9     Document Type: Article

References (31)

1. Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 294:1625-1633
2. Shan MR, Hasselblad V, Stevenson LW, Binanay C, O'Connor CM, Sopko G, Califf RM (2005) Impact of the pulmonary artery in critically ill patients: Meta-analysis of randomized clinical trials. JAMA 294:1664-1670
3. Harvey S, Harison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K (2005) Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomized controlled trial. Lancet 366:472-477
4. Hall JB (2005) Searching for evidence to support pulmonary artery catheter use in critically ill patients. JAMA 294:1693-1694
5. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527-1533
6. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788-1794
7. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G (2003) Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24:1710-1718
8. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A (2001) A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Fail 7:21-29
9. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832
10. Richards M, Troughton EJ (2004) NT-proBNP in heart failure: Therapy decisions and monitoring. Eur J Heart Fail 6:351-354
11. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton P, Maisel A (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol 37:386-391
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367
13. Quinones MA, Wagoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, Ribeiro LG, Miller RR (1981) A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 64:744-753
14. Gould KL, Lipscomb K, Hamilton GW, Kennedy JW (1974) Relation of left ventricular shape, function and wall stress in man. Am J Cardiol 34:627-634
15. Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF (2003) Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 91:780-784
16. Blackledge HM, Tomilson J, Squire IB (2003) Prognosis for patients newly admitted to hospital with heart failure: Survival trends in 12.220 index admissions in Leicestershire 1993-2001. Heart 89:615-620
17. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S (1989) Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 14:564-570
18. Smith TW, Kelly RA, Stevenson LW, Massie B, Packer M, Pitt B, Goldstein S (1997) Management of heart failure. In: Braunwald E (ed) Heart disease, 5th edn. Saunders, Philadelphia, pp 492-514
19. Oh JK (2005) Echocardiography as a non Schwan-Ganz catheter Circulation 111:3192-3194
20. Woltjer HH, Bogaard HJ, Bronzwaer JG, deCock CC, de Vries PM (1997) Prediction of pulmonary capillary wedge pressure and assessment of stroke volume by noninvasive impedance cardiography. Am Heart J 134:450-455
21. Dokainish H, Zoghbi WA, Lakkis NM, Al-Bakshy F, Dhir M, Quinones MA, Nagueh SF (2004) Optimal noninvasive assessment of left ventricular filling pressures. A comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109:2432-2439
22. Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 30:8-18
23. Thomas JD, Weyman AE (1991) Echo Doppler evaluation of left ventricular diastolic function: Physics and physiology. Circulation 84:977-990
24. Temporelli P, Giannuzzi P, Nicolosi GL, Lattini R, Franzosi MG, Gentile F, Tavazzi L, Maggioni AP (2004) Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction. Results of the GISSI-3 echo substudy. J Am Coll Cardiol 43:1646-1653
25. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL (2004) Plasma B-type natriuretic peptide levels in systolic heart failure. J Am Coll Cardiol 43:416-422
26. Maisel AS (2003) Neseritide: A new therapy for the treatment of heart failure. Cardiovasc Toxicol 3:37-42
27. Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T (2006) Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 21:344-349
28. McKie PM, Burnett JC Jr (2005) B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities. Mayo Clin Proc 80:1029-1036
29. Richards AM, Throughton R, Laichbury J, Doughty R, Wright S (2005) Guiding and monitoring of heart failure therapy with NT-Pro BNP: concepts and clinical studies. J Card Fail 11:S34-S37
30. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP (2005) Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 45:1667-1671
31. Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL (2004) Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32:1643-1647